On SWE-Bench Verified, the model achieved a score of 70.6%. This performance is notably competitive when placed alongside ...

Aytu BioPharma Inc (AYTU) reports a mixed quarter with decreased revenues but a promising start for its novel depression treatment, EXXUA.

M (MMM) is back in focus after its board declared a first quarter 2026 dividend of $0.78 per share, payable on March 12 to shareholders of record as of February 13, 2026. See our latest analysis for ...

In the course of its diplomatic contacts with the United States, Israel insists on a list of demands regarding Washington’s relations with Tehran, Israel’s Channel 12 said citing a high-ranking ...